机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡
Cancer Center Karolinska Department of Oncology and Pathology Karolinska Institute and Hospital Cancer Center Karolinska R8:00 S-171 76 Stockholm Sweden;
Cancer Center Karolinska Department of Oncology and Pathology Karolinska Institute and Hospital Cancer Center Karolinska R8:00 S-171 76 Stockholm Sweden;
Cancer Center Karolinska Department of Oncology and Pathology Karolinska Institute and Hospital Cancer Center Karolinska R8:00 S-171 76 Stockholm Sweden;
Cancer Center Karolinska Department of Oncology and Pathology Karolinska Institute and Hospital Cancer Center Karolinska R8:00 S-171 76 Stockholm Sweden;
Chemical biology; Apoptosis; AKT; Microtubuli-interacting agents;
机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡
机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡
机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡
机译:低功率激光照射通过Akt激活抑制Aβ_(25-35)诱导的细胞凋亡。
机译:多靶点受体酪氨酸激酶抑制剂利尼法尼(ABT-869)通过磷酸肌醇3激酶(PI3K)/ AKT依赖性信号传导途径诱导凋亡并抑制白血病细胞的增殖。
机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡
机译:条件药物筛选显示有丝分裂抑制剂诱导AKT / PKB不敏感凋亡